Lymphoma risk in inflammatory bowel disease: influences of referral bias and therapy

Gastroenterology. 2001 Nov;121(5):1239-42. doi: 10.1053/gast.2001.29271.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Humans
  • Immunosuppressive Agents / adverse effects
  • Inflammatory Bowel Diseases / complications*
  • Inflammatory Bowel Diseases / therapy
  • Lymphoma / etiology*
  • Risk

Substances

  • Immunosuppressive Agents